Nature Communications (Jan 2024)

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

  • Nasser K. Altorki,
  • Zachary H. Walsh,
  • Johannes C. Melms,
  • Jeffery L. Port,
  • Benjamin E. Lee,
  • Abu Nasar,
  • Cathy Spinelli,
  • Lindsay Caprio,
  • Meri Rogava,
  • Patricia Ho,
  • Paul J. Christos,
  • Ashish Saxena,
  • Olivier Elemento,
  • Bhavneet Bhinder,
  • Casey Ager,
  • Amit Dipak Amin,
  • Nicholas J. Sanfilippo,
  • Vivek Mittal,
  • Alain C. Borczuk,
  • Silvia C. Formenti,
  • Benjamin Izar,
  • Timothy E. McGraw

DOI
https://doi.org/10.1038/s41467-023-44575-3
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.